CMS Measure ID: #110 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Community, Population andContinue reading “2023 # 110 Preventive Care and Screening: Influenza Immunization”
CQM/MVP Archive
2023 # 047 Advance Care Plan
CMS Measure ID: #47 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: Yes NQS Domain: Communication and CareContinue reading “2023 # 047 Advance Care Plan”
2023 # 039 Screening for Osteoporosis for Women Aged 65-85 Years of Age
CMS Measure ID: #39 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Effective Clinical CareContinue reading “2023 # 039 Screening for Osteoporosis for Women Aged 65-85 Years of Age”
2023 # 008 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS Measure ID: #8 Collection Type: CQM Reporting Frequency: 1: Once per patient/year; 2: Every Visit Outcome: No High Priority: No NQS Domain: EffectiveContinue reading “2023 # 008 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)”
2023 # 007 Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <= 40%)
CMS Measure ID: #7 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Effective Clinical CareContinue reading “2023 # 007 Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <= 40%)"
2023 # 006 Coronary Artery Disease (CAD): Antiplatelet Therapy
CMS Measure ID: #6 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Effective Clinical CareContinue reading “2023 # 006 Coronary Artery Disease (CAD): Antiplatelet Therapy”
2023 # 005 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS Measure ID: #5 Collection Type: CQM Reporting Frequency: 1: Once per patient/year; 2: Every Visit Outcome: No High Priority: No NQS Domain: EffectiveContinue reading “2023 # 005 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)”